<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01418482</url>
  </required_header>
  <id_info>
    <org_study_id>MxB Ag 02</org_study_id>
    <nct_id>NCT01418482</nct_id>
  </id_info>
  <brief_title>Evaluation of Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns</brief_title>
  <official_title>An Open Non-controlled Post-marketing Investigation Evaluating the Experience of Using a Self- Adherent Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Molnlycke Health Care AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Molnlycke Health Care AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigation is designed as an open, non-controlled, post-marketing investigation.
      Subjects with at least one second degree burn less than 9.5x15 cm in size at 1-3 sites will
      be included. The subject is allowed to have more than one burn on the body but only one
      should be included in the investigation. Each subject will be followed/assessed according to
      normal hospital routine 1-3 times per week for a maximum of 3 weeks or until desired
      treatment effect is obtained if that occurs earlier. All dressing changes will be done
      according to clinical routine and will follow the IFU (instruction for use). All dressing
      changes will be registered in a dressing log. Additional compression bandaging, gauze wrap,
      or such are allowed and should be reported as well
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At baseline, subject characteristics will be registered together with subject status of
      health and status of the burn, and current treatment of the burn.

      At each visit the following variables will be collected where applicable:

        -  Investigator's/Nurse evaluation of

             -  Overall experience of the dressing

             -  Ability of dressing to stay in place (not at baseline)

             -  Conformability of the dressing

             -  Handling at application

             -  Ease of removal of the dressing (not at baseline)

        -  Subject evaluation of

             -  Overall experience of the dressing

             -  Comfort of the dressing

             -  Conformability of the dressing

        -  Pain before, during and after removal of dressing according to VAS

        -  Status of skin

        -  Burn status: width x length, exudate details and signs of inflammation/infection

      In addition the following variables should be evaluated at each visit:

        -  Concomitant medication/treatment

        -  Adverse Event/Adverse Device Effect (AE/ADE)

        -  Serious Adverse Event/Serious Adverse Device Effect (sAE/sADE)

      Photos will be taken before Mepilex Border Ag is removed, after removal, before cleansing,
      and after cleansing. All photos must include a sticker marker with subject code, visit number
      and date, and an indication of whether pre-/post removal, pre-/post cleansing. The stick
      marker also contains a ruler. Detailed instructions on how to take the photos is given in
      Appendix 14.2

      At each visit the subject will give the assessment concerning the comfort and stay-on-ability
      of the dressing. The investigator will also give an assessment at each visit concerning
      handling, conformability and ability of dressing to stay in place.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the Experience of Using Mepilex Border Ag ( a Silver Dressing) in Normal Clinical Practice</measure>
    <time_frame>3 weeks</time_frame>
    <description>burns healed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the Comfort</measure>
    <time_frame>3 weeks</time_frame>
    <description>Comfort level and overall experience were each assessed using a scale that ranged from very poor to very good.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>3 weeks</time_frame>
    <description>To evaluate pain during dressing removal at visit 4,(after one week) with John Hopkins pain scale. Measured 0=no pain, 100= worst pain, scale from 0-100 mm</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Mepilex Border Ag</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mepilex Border Ag, a silver dressing will be used</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mepilex Border Ag</intervention_name>
    <description>a silver dressing</description>
    <arm_group_label>Mepilex Border Ag</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject with a small partial thickness burn (&lt; 9.5x15 cm) where an antimicrobial
             action is indicated as judged by the investigator*

          2. Male or female, 18 years and above, both in- and out-patient subjects

          3. Signed Informed Consent Form

        Exclusion Criteria:

          1. Wound size equal to or above 9.5x15cm for the selected burn for the investigation

          2. Pregnant and/or breastfeeding women

          3. Subject not expected to follow the investigation procedures or applicable for
             investigation according to the judgment of the investigator

          4. Subjects with known sensitivity to silver or any other contents of the dressing

          5. Subjects previously included in this investigation

          6. Subjects included in other ongoing clinical investigation at present or during the
             past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fredrik Huss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Akademiska Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Briva/Hpk</name>
      <address>
        <city>Link√∂ping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Plastikkirurgiska kliniken, UAS BRIVA</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2011</study_first_submitted>
  <study_first_submitted_qc>August 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2011</study_first_posted>
  <results_first_submitted>April 7, 2016</results_first_submitted>
  <results_first_submitted_qc>March 22, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 3, 2017</results_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Mepilex Border Ag</title>
          <description>Mepilex Border Ag, a silver dressing</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>small partial thickness burns</population>
      <group_list>
        <group group_id="B1">
          <title>Mepilex Border Ag</title>
          <description>Mepilex Border Ag, ( a silver dressing)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.5" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Evaluate the Experience of Using Mepilex Border Ag ( a Silver Dressing) in Normal Clinical Practice</title>
        <description>burns healed</description>
        <time_frame>3 weeks</time_frame>
        <population>small thickness partial burns</population>
        <group_list>
          <group group_id="O1">
            <title>Mepilex Border Ag</title>
            <description>Mepilex Border Ag</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluate the Experience of Using Mepilex Border Ag ( a Silver Dressing) in Normal Clinical Practice</title>
          <description>burns healed</description>
          <population>small thickness partial burns</population>
          <units>burns healed</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Evaluate the Comfort</title>
        <description>Comfort level and overall experience were each assessed using a scale that ranged from very poor to very good.</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mepilex Border Ag</title>
            <description>Mepilex Border Ag</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluate the Comfort</title>
          <description>Comfort level and overall experience were each assessed using a scale that ranged from very poor to very good.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Conformability Good -very Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall experience good-very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain</title>
        <description>To evaluate pain during dressing removal at visit 4,(after one week) with John Hopkins pain scale. Measured 0=no pain, 100= worst pain, scale from 0-100 mm</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mepilex Border Ag</title>
            <description>Mepilex Border Ag</description>
          </group>
        </group_list>
        <measure>
          <title>Pain</title>
          <description>To evaluate pain during dressing removal at visit 4,(after one week) with John Hopkins pain scale. Measured 0=no pain, 100= worst pain, scale from 0-100 mm</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Mepilex Border Ag</title>
          <description>Mepilex Border Ag</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Swelling of left hand</sub_title>
                <description>Swelling of left hand</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection left arm, no study burn</sub_title>
                <description>Infection left arm, no study burn</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Fredrik Huss</name_or_title>
      <organization>Uppsala Akademiska Hospital, Dept. of Plastic Surgery</organization>
      <phone>+46 771 405 405</phone>
      <email>Fredrik.Huss@surgsci.uu.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

